Authors: YuNan Hsu Calvin Q Pan Ali Abbasi Victor Xia Raghav Bansal KeQin Hu
Publish Date: 2014/02/12
Volume: 59, Issue: 4, Pages: 865-871
Abstract
The modified normal alanine aminotransferase ALT value ie males 30 and females 19 IU/L is a better criteria associated with histological activity in chronic hepatitis B CHB This study was aimed to assess if the modified ALT criteria could be better associated with disease phases in a cohort of Asian Americans AsAm with CHBThis twocenter retrospective study evaluated 198 nontreated AsAm with CHB and a mean followup of 21 months Both conventional and modified ALT criteria were used to determine the differences and clinical value using modified ALT criteria in classifying CHB phasesAmong HBeAg + patients 293 HBV precore PC and basal core promoter BCP mutations were detected in 244 and 313 respectively Using baseline conventional ALT criteria 97/153 634 patients could be categorized into CHB phases 1 to 4 whereas 56/153 366 were indeterminate Using the modified ALT criteria 43 281 patients had phase changes of which 31/43 721 were moved from phase 1 and indeterminate to phases 2 and 4 more active CHB phases In 13/31 of these patients with liver biopsy 6 194 reported stage 2–4 fibrosis and 10 323 reported grade 1–2 inflammation Using modified ALT criteria to evaluate 48/153 patients with full data at baseline and the end of 1year followup we observed that 19/48 396 changed their CHB phases 5/48 104 moved from phases 1 and 3 to phases 2 and 4 2/48 42 remained in the active phases 10/48 208 became indeterminateDr KeQin Hu has received research or educational grants from Gilead Bristol Myers Squibb Genentech and Merck He also serves as speaker bureau for Gilead Bristol Myers Squibb Genentech and Merck Dr Calvin Q Pan has received research grants from Gilead Bristol Myers Squibb Novartis and Roche He also serves as a consultant advisor and speakers bureau for Gilead and Bristol Myers Squibb
Keywords: